AR060622A1 - Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoico - Google Patents
Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoicoInfo
- Publication number
- AR060622A1 AR060622A1 ARP070101727A ARP070101727A AR060622A1 AR 060622 A1 AR060622 A1 AR 060622A1 AR P070101727 A ARP070101727 A AR P070101727A AR P070101727 A ARP070101727 A AR P070101727A AR 060622 A1 AR060622 A1 AR 060622A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- iloxi
- methyl
- give
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 12
- 239000002904 solvent Substances 0.000 abstract 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- GOOHAUXETOMSMM-GSVOUGTGSA-N R-propylene oxide Chemical compound C[C@@H]1CO1 GOOHAUXETOMSMM-GSVOUGTGSA-N 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 239000012022 methylating agents Substances 0.000 abstract 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
El compuesto 1 se ha mostrado que va a ser util para el tratamiento de ciertos tipos de cáncer. Reivindicacion 1: Un proceso para la preparacion del compuesto de la formula (1) caracterizado porque comprende las etapas de: (a) hacer reaccionar el compuesto de la formula (2) con un agente de metilacion en un solvente adecuado para producir el compuesto de formula (3), b) el cual se hace reaccionar en una oxidacion continua seguido por una reaccion de apagado para preparar el compuesto de formula (4) y proteccion para convertir el compuesto de formula (4) al compuesto de formula (5), c) clorar el compuesto de formula (5) para dar el compuesto de formula (6), d) el cual es unido con el compuesto de formula (7) para dar el compuesto de formula (8), que es cristalizado opcionalmente para mejorar la calidad, y e) el cual es desprotegido subsiguientemente y se hace reaccionar con el oxido de (R)-(+)-propileno en un solvente adecuado, y opcionalmente recristalizado para mejorar la calidad, para dar el compuesto de formula (9), f) el cual se hace reaccionar con una Cbz-L-alanina y un agente de union para dar el compuesto de la formula (10).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74530006P | 2006-04-21 | 2006-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060622A1 true AR060622A1 (es) | 2008-07-02 |
Family
ID=38357966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101727A AR060622A1 (es) | 2006-04-21 | 2007-04-20 | Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoico |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7671199B2 (es) |
| EP (1) | EP2010538B1 (es) |
| JP (1) | JP5203353B2 (es) |
| KR (1) | KR101423789B1 (es) |
| CN (1) | CN101472927B (es) |
| AR (1) | AR060622A1 (es) |
| AU (1) | AU2007240453B2 (es) |
| BR (1) | BRPI0710691A2 (es) |
| CA (1) | CA2650059A1 (es) |
| CL (2) | CL2007001141A1 (es) |
| DK (1) | DK2010538T3 (es) |
| EA (1) | EA019693B1 (es) |
| ES (1) | ES2399379T3 (es) |
| HR (1) | HRP20130099T1 (es) |
| IL (1) | IL194715A (es) |
| MX (1) | MX2008013232A (es) |
| NO (1) | NO20084326L (es) |
| PE (1) | PE20080193A1 (es) |
| PL (1) | PL2010538T3 (es) |
| PT (1) | PT2010538E (es) |
| SI (1) | SI2010538T1 (es) |
| TW (1) | TWI378100B (es) |
| WO (1) | WO2007124332A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007038648A1 (en) * | 2005-09-27 | 2007-04-05 | Bristol-Myers Squibb Company | Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| US20120135875A1 (en) * | 2008-02-29 | 2012-05-31 | Bristol-Myers Squibb Company | Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| AR074830A1 (es) | 2008-12-19 | 2011-02-16 | Cephalon Inc | Pirrolotriazinas como inhibidores de alk y jak2 |
| EP3864418A1 (en) | 2018-10-08 | 2021-08-18 | Applied Photophysics Limited | System and method for analysing the composition of a quenched flow reaction liquid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982265B1 (en) * | 1999-05-21 | 2006-01-03 | Bristol Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| TWI272271B (en) * | 2002-07-19 | 2007-02-01 | Bristol Myers Squibb Co | Process for preparing certain pyrrolotriazine compounds |
| TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
| US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7432373B2 (en) * | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| US7393667B2 (en) * | 2005-05-31 | 2008-07-01 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| WO2007038648A1 (en) * | 2005-09-27 | 2007-04-05 | Bristol-Myers Squibb Company | Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
-
2007
- 2007-04-19 KR KR1020087025577A patent/KR101423789B1/ko not_active Expired - Fee Related
- 2007-04-19 ES ES07760872T patent/ES2399379T3/es active Active
- 2007-04-19 CN CN2007800232897A patent/CN101472927B/zh not_active Expired - Fee Related
- 2007-04-19 EA EA200802171A patent/EA019693B1/ru not_active IP Right Cessation
- 2007-04-19 MX MX2008013232A patent/MX2008013232A/es active IP Right Grant
- 2007-04-19 WO PCT/US2007/066911 patent/WO2007124332A1/en not_active Ceased
- 2007-04-19 EP EP07760872A patent/EP2010538B1/en active Active
- 2007-04-19 DK DK07760872.7T patent/DK2010538T3/da active
- 2007-04-19 HR HRP20130099TT patent/HRP20130099T1/hr unknown
- 2007-04-19 PL PL07760872T patent/PL2010538T3/pl unknown
- 2007-04-19 SI SI200731167T patent/SI2010538T1/sl unknown
- 2007-04-19 AU AU2007240453A patent/AU2007240453B2/en not_active Ceased
- 2007-04-19 PT PT77608727T patent/PT2010538E/pt unknown
- 2007-04-19 JP JP2009506761A patent/JP5203353B2/ja not_active Expired - Fee Related
- 2007-04-19 CA CA002650059A patent/CA2650059A1/en not_active Abandoned
- 2007-04-19 BR BRPI0710691-2A patent/BRPI0710691A2/pt not_active IP Right Cessation
- 2007-04-20 AR ARP070101727A patent/AR060622A1/es unknown
- 2007-04-20 US US11/737,787 patent/US7671199B2/en active Active
- 2007-04-20 PE PE2007000492A patent/PE20080193A1/es not_active Application Discontinuation
- 2007-04-20 TW TW096114144A patent/TWI378100B/zh not_active IP Right Cessation
- 2007-04-20 CL CL2007001141A patent/CL2007001141A1/es unknown
-
2008
- 2008-10-12 IL IL194715A patent/IL194715A/en not_active IP Right Cessation
- 2008-10-16 NO NO20084326A patent/NO20084326L/no not_active Application Discontinuation
-
2010
- 2010-05-28 CL CL2010000554A patent/CL2010000554A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101472927B (zh) | 2012-07-04 |
| EA200802171A1 (ru) | 2009-08-28 |
| PL2010538T3 (pl) | 2013-04-30 |
| AU2007240453B2 (en) | 2012-04-12 |
| JP2009534413A (ja) | 2009-09-24 |
| KR101423789B1 (ko) | 2014-07-30 |
| NO20084326L (no) | 2008-11-18 |
| SI2010538T1 (sl) | 2013-06-28 |
| EP2010538B1 (en) | 2012-12-05 |
| CL2007001141A1 (es) | 2008-01-18 |
| PE20080193A1 (es) | 2008-03-10 |
| EA019693B1 (ru) | 2014-05-30 |
| IL194715A (en) | 2013-10-31 |
| US7671199B2 (en) | 2010-03-02 |
| TWI378100B (en) | 2012-12-01 |
| AU2007240453A1 (en) | 2007-11-01 |
| KR20090008246A (ko) | 2009-01-21 |
| EP2010538A1 (en) | 2009-01-07 |
| JP5203353B2 (ja) | 2013-06-05 |
| US20070249610A1 (en) | 2007-10-25 |
| MX2008013232A (es) | 2008-10-21 |
| BRPI0710691A2 (pt) | 2011-08-23 |
| WO2007124332A1 (en) | 2007-11-01 |
| CN101472927A (zh) | 2009-07-01 |
| TW200808799A (en) | 2008-02-16 |
| HRP20130099T1 (hr) | 2013-03-31 |
| CA2650059A1 (en) | 2007-11-01 |
| ES2399379T3 (es) | 2013-04-01 |
| PT2010538E (pt) | 2013-02-22 |
| CL2010000554A1 (es) | 2010-10-15 |
| DK2010538T3 (da) | 2013-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061422A1 (es) | Tigeciclina y metodos para preparar 9-nitrominociclina | |
| CR8975A (es) | Proceso para la produccion de derivados de amina opticamente activos | |
| CY1111170T1 (el) | Ενωσεις διαρυλ αιθερα ουριας | |
| NO20060544L (no) | Enzymatiske prosesser for produksjon av 4-substituerte 3-hydroksysmorsyrederivater og naerliggende cyano, hydroksy substituerte karboksylsyre estere | |
| MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
| AR050518A1 (es) | Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv | |
| AR074863A1 (es) | Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc | |
| AU2016237099B2 (en) | Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same | |
| AR060622A1 (es) | Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoico | |
| UA94603C2 (ru) | Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления | |
| PE20090833A1 (es) | Tigeciclina y metodos para preparar intermedios | |
| MA29690B1 (fr) | Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine | |
| BR112013003992A2 (pt) | método de produção | |
| AR076516A1 (es) | Derivados de oxa-azaespiro[3.3]heptan-6-ilo, metodo e intermediarios para su preparacion, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades mediadas por el receptor mch1. | |
| PE20081497A1 (es) | Nuevo procedimiento para la preparacion de 4-4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona) | |
| PL1751093T3 (pl) | Podstawione pochodne kwasu cykloheksylooctowego | |
| MX2010009876A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente. | |
| AR066054A1 (es) | Proceso para preparar galantamina | |
| CR9208A (es) | Procesos para la preparacion de alcoholes de aminoetoxibencilo | |
| TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| TW200710076A (en) | Process for producing aldehyde with 2-position branched long-chain alkyl | |
| BR112014006844A2 (pt) | composições e métodos relacionados ao ácido deoxicólico e seus polimorfos | |
| WO2008111563A1 (ja) | 鉄サラン錯体触媒を用いた光学活性スルホキシド化合物の製造法 | |
| BRPI0507318A (pt) | métodos para reduzir um composto, para a produção de calcipotriol ou monoidrato de calcipotriol, e de um composto, e de reação da mistura de compostos, composto, e, uso de um composto | |
| BR112012006519A2 (pt) | síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |